Michael P. Kelly served as Director of Duke University Eye Center's clinical and research imaging department from 2005 to 2023, and now holds the position of Director of Duke Remote Diagnostic Screening. He previously ran the clinical and research imaging programs at West Coast Retina Medical Group, California Pacific Medical Center, Cleveland Clinic's Cole Eye Institute, and the Cincinnati Eye Institute. Michael stewarded these departments through the imaging requirements of dozens of national clinical trials, including the anti-VEGF studies, the sustained-release and treat-and-extend trials, the collaborative ocular melanoma study (COMS), the cytomegalovirus retinitis trials, and the ETDRS, AREDS, AGIS, and CATT trials. He is a Fellow and two-term Past President of the Ophthalmic Photographers' Society (OPS), has served on the editorial boards for the American Academy of Ophthalmology and the OPS, has published forty-six peer-reviewed papers in seventeen different ophthalmology and biomedical optics journals, served as guest editor for a special issue on imaging intraocular tumors, and has written chapters in four textbooks. He has published works across four disciplines: ophthalmic imaging, biomedical optics, photography, and all subspecialties within ophthalmology. Michael has given over two hundred lectures and has been an invited speaker twice at Bascom Palmer Eye Institute, twice at Ohio State University, six times at the University of California at Berkeley, the University of California at San Francisco, Brown University and the Cleveland Clinic. He has given talks for conferences at Harvard and Oxford, in Singapore, Chile, and the United Arab Emirates, and was the Keynote Speaker at Aalborg University's 2022 Oftalmologisk FotoSymposium in Denmark.